All IQVIA network sites receive a Quality Assurance (QA) Audit and Medical Safety Assessment against ethical, regulatory, medical and quality standards. The assessment also guides trial designs and types of drug candidates that can be investigated at each site. In addition to ensuring rigorous safety and quality standards, the IQVIA network also gives you important operational advantages. It’s a choice that lets you
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Bring your biosimilar to market faster by tapping into unparalleled data, technology, advanced analytics, and scientific expertise.